Dose Distribution Analysis of Axillary Lymph Nodes for Three-Dimensional Conformal Radiotherapy With a Field-in-Field Technique for Breast Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 1, 2009, Pages 80-87

  Ohashi, Toshio ^a   Takeda, Atsuya ^b   Shigematsu, Naoyuki ^a   Fukada, Junichi ^a   Sanuki, Naoko ^b   Amemiya, Atsushi ^b   Kubo, Atsushi ^a  

^a KEIO UNIVERSITY   (Japan)

^b Ofuna Chuo Hospital   (Japan)

Author keywords

Axillary node; Breast cancer; Dose volume histogram; Radiotherapy; Three dimensional conformal radiotherapy

Indexed keywords

BIOLOGICAL ORGANS; DOSIMETRY; FLUORESCENT SCREENS; HISTOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY; TELEVISION PICTURE TUBES;

AXILLARY LYMPH NODES; AXILLARY NODE; AXILLARY NODES; BREAST CANCER; BREAST CANCERS; CONFORMAL RADIOTHERAPIES; DOSE DISTRIBUTIONS; DOSE-VOLUME HISTOGRAM; MULTILEAF COLLIMATORS; NORMAL TISSUES; RADIATION FIELDS; THREE-DIMENSIONAL CONFORMAL RADIOTHERAPY;

THREE DIMENSIONAL;

ADULT; AGED; ARTICLE; AXILLA; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; COLLIMATOR; COMPUTER ASSISTED RADIOTHERAPY; DOSIMETRY; HEART; HISTOGRAM; HUMAN; LUNG; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION FIELD;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BODY BURDEN; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; MIDDLE AGED; RADIOMETRY; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK ASSESSMENT;

EID: 57649098487     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.04.003     Document Type: Article

References (40)

1. Cady B. The need to reexamine axillary lymph node dissection in invasive cancer. Cancer 73 (1994) 505-508
2. Haffty B.G., Ward B., Pathare P., et al. Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15 (1997) 691-700
3. Dent D.M. Axillary lymphadenectomy for breast cancer: Paradigm shifts and pragmatic surgeons. Arch Surg 131 (1996) 1125-1127
4. Cady B., Stone M.D., and Wayne J. New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218 (1993) 338-349
5. Halverson K.J., Taylor M.E., Perez C.A., et al. Regional nodal management and patterns of failure following conservative surgery and radiation therapy for Stage 1 and 2 breast cancer. Int J Radiat Oncol Biol Phys 26 (1993) 593-599
6. Hoskin P.J., Rajan B., Ebbs S., et al. Selective avoidance of lymphatic radiotherapy in the conservative management of early breast cancer. Radiother Oncol 25 (1992) 83-88
7. Kuznetsova M., Graybill J.C., Zusag T.W., et al. Omission of axillary nymph node dissection in early-stage breast cancer: Effect on treatment outcome. Radiology 197 (1995) 507-510
8. Ogawa Y., Nishioka A., Inomata T., et al. Conservation treatment intensified with tamoxifen and CAF chemotherapy without axillary dissection in cancer patients with clinically-negative axillary nodes. Oncol Rep 6 (1999) 801-805
9. Wong J.S., Recht A., Beard C.J., et al. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys 39 (1997) 915-920
10. Harlow S.P., and Krag D.N. Sentinel lymph node-why study it: Implications of the B-32 study. Semin Surg Oncol 20 (2001) 224-229
11. Takeda A., Shigematsu N., Kondo M., et al. The modified tangential irradiation technique for breast caner: How to cover the entire axillary region. Int J Radiat Oncol Biol Phys 46 (2000) 815-822
12. Takeda A., Shigematsu N., Ikeda T., et al. Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histogram. Int J Radiat Oncol Biol Phys 58 (2004) 1280-1288
13. Thilmann C., Zabel A., Milker-Zabel S., et al. Number and orientation of beams in inversely planned intensity-modulated radiotherapy of the female breast and the parasternal lymph nodes. Am J Clin Oncol 26 (2003) e136-e143
14. Krueger E.A., Fraass B.A., McShan D.L., et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1023-1037
15. Beckham W.A., Pepescu C.C., Patenaude V.V., et al. Is multibeam IMRT better than standard treatment for patients with left-sided breast cancer?. Int J Radiat Oncol Biol Phys 69 (2007) 918-924
16. Paszat L.F., Mackillop W.J., Groome P.A., et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer: A population-based study in Ontario, Canada. Int J Radiat Oncol Biol Phys 43 (1999) 755-762
17. Paszat L.F., Mackillop W.J., Groome P.A., et al. Mortality from myocardial infarction after adjuvant radiotherapy for breast cancer in the surveillance, epidemiology, and end-results cancer registries. J Clin Oncol 16 (1998) 2625-2631
18. Gyenes G., Rutqvist L.E., Liedberg A., et al. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 48 (1998) 185-190
19. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
20. Hancock S.L., Tucker M.A., and Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 270 (1993) 1949-1955
21. Harris J.R., Lippman M.E., et al. Diseases of the breast. 2nd ed. (2000), Lippincott, Williams & Wilkins, Philadelphia p. 5-8, 404, 546-549
22. Reznik J., Cicchetti M.G., Degaspe B., et al. Analysis of axillary coverage during tangential radiation therapy to the breast. Int J Radiat Oncol Biol Phys 61 (2005) 163-168
23. Aristei C., Chionne F., Marsella A.R., et al. Evaluation of level I and II axillary nodes included in the standard breast tangential fields and calculation of the administered dose: Results of a prospective study. Int J Radiat Oncol Biol Phys 51 (2001) 69-73
24. Reed D.R., Lindsley S.K., Mann G.N., et al. Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 61 (2005) 358-364
25. Schlembach P.J., Buchholz T.A., Ross M.I., et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 51 (2001) 671-678
26. Dogan N., Cuttino L., Lloyd R., et al. Optimized dose coverage of regional lymph nodes in breast cancer: The role of intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68 (2007) 1238-1250
27. Hortobagyi G.N. Trastuzumab in the treatment of breast cancer. N Engl J Med 353 (2005) 1734-1736
28. Weber D.C., Ares C., Lomax A.J., et al. Radiation therapy planning with photons and protons for early and advanced breast cancer: An overview. Radiat Oncol 1 (2006) 22
29. Polgar C., Sulyok Z., Fodor J., et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a Phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80 (2002) 121-128
30. Vicini F.A., Baglan K.L., Kestin L.L., et al. Accelerated treatment of breast cancer. J Clin Oncol 19 (2001) 1993-2001
31. Vicini F.A., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 (2003) 1247-1253
32. Pierce S.M., Recht A., Lingos T.I., et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23 (1992) 915-923
33. Marks L.B., Fan M., Clough R., et al. Radiation-induced pulmonary injury: Symptomatic versus subclinical endpoints. Int J Radiat Biol 76 (2000) 469-475
34. Hall E.J., and Wuu C.S. Radiation-induced second cancers: The impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 (2003) 83-88
35. Gao X., Fisher S.G., and Emami B. Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study. Int J Radiat Oncol Biol Phys 56 (2003) 1038-1045
36. Roychoudhuri R., Evans H., Robinson D., et al. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer 91 (2004) 868-872
37. Kirova Y.M., Gambotti L., De Rycke Y., et al. Risk of second malignancies after adjuvant radiotherapy for breast cancer: A large-scale, single-institution review. Int J Radiat Oncol Biol Phys 68 (2007) 359-363
38. Fowble B.L., Solin L.J., Schultz D.J., and Goodman R.L. Ten-year results of conservative surgery and irradiation for Stage I and II breast cancer. Int J Radiat Oncol Biol Phys 21 (1991) 269-277
39. Pierce S.M., Recht A., Lingos T.I., et al. Long-term radiation complication following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23 (1992) 915-923
40. Woo T.C., Pignol J.P., Rakovitch E., et al. Body radiation exposure in breast cancer radiotherapy: Impact of breast IMRT and virtual wedge compensation techniques. Int J Radiat Oncol Biol Phys 65 (2006) 52-58